Concepedia

Ashraf Badros

AB

Statistics

Publications

141

Citations

13.5K

H-Index

58

Active since

2000

Affiliations

University of Maryland, Baltimore(Current)

Dana-Farber Cancer Institute

U-M Rogel Cancer Center

Emory University

Cornell University

Ashraf Badros is an author at University of Maryland, Baltimore specializing in medicine, multiple myeloma, and multiple myeloma therapy.

ORCID

Publications per year

2000–2025

141

Publications

141

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl et al. · Nature Medicine · 2015 · 848 citations · Full text

, , +16

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros et al. · The Lancet Oncology · 2019 · 796 citations

, , +11

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

, , +15

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

Ashraf Badros, Dianna Weikel, Andrew Salama et al. · Journal of Clinical Oncology · 2006 · 596 citations

, , +12

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy

Maurizio Zangari, Elias Anaissie, Bart Barlogie et al. · Blood · 2001 · 496 citations · Full text

, , +14

1–5 of 141